| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 123.638 | 266.113 | 268.632 | 252.895 |
| Total Income - EUR | - | - | - | - | - | - | 123.638 | 266.113 | 268.637 | 252.895 |
| Total Expenses - EUR | - | - | - | - | - | - | 62.226 | 145.639 | 156.531 | 150.745 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 61.412 | 120.473 | 112.106 | 102.150 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 60.676 | 117.866 | 109.818 | 94.714 |
| Employees | - | - | - | - | - | - | 4 | 5 | 6 | 5 |
Check the financial reports for the company - Medoptic Eye S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 7.799 | 21.643 | 15.837 | 12.388 |
| Current Assets | - | - | - | - | - | - | 59.215 | 116.359 | 134.243 | 103.281 |
| Inventories | - | - | - | - | - | - | 9.190 | 25.464 | 39.572 | 49.963 |
| Receivables | - | - | - | - | - | - | 15.952 | 19.316 | 5.116 | 45.338 |
| Cash | - | - | - | - | - | - | 34.073 | 71.579 | 89.555 | 7.980 |
| Shareholders Funds | - | - | - | - | - | - | 60.716 | 117.914 | 133.142 | 94.763 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 6.298 | 20.088 | 16.938 | 20.906 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Medoptic Eye S.r.l.